| Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals LK Vibholm, CV Konrad, MH Schleimann, G Frattari, A Winckelmann, ... Aids 33 (8), 1315-1325, 2019 | 78 | 2019 |
| Macromolecular antiviral agents against Zika, Ebola, SARS, and other pathogenic viruses F Schandock, CF Riber, A Röcker, JA Müller, M Harms, P Gajda, ... Advanced Healthcare Materials 6 (23), 1700748, 2017 | 58 | 2017 |
| Albumin–polymer–drug conjugates: long circulating, high payload drug delivery vehicles AAA Smith, K Zuwala, O Pilgram, KS Johansen, M Tolstrup, ... ACS Macro Letters 5 (10), 1089-1094, 2016 | 40 | 2016 |
| Macromolecular (pro) drugs in antiviral research AAA Smith, MBL Kryger, BM Wohl, P Ruiz-Sanchis, K Zuwala, M Tolstrup, ... Polymer Chemistry 5 (22), 6407-6425, 2014 | 40 | 2014 |
| Macromolecular prodrugs of ribavirin: towards a treatment for co-infection with HIV and HCV AAA Smith, K Zuwala, MBL Kryger, BM Wohl, C Guerrero-Sanchez, ... Chemical Science 6 (1), 264-269, 2015 | 33 | 2015 |
| Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells P Ruiz‐Sanchis, BM Wohl, AAA Smith, K Zuwala, J Melchjorsen, ... Advanced Healthcare Materials 4 (1), 65-68, 2015 | 28 | 2015 |
| TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes MH Schleimann, ML Kobberø, LK Vibholm, K Kjær, LB Giron, ... EBioMedicine 45, 328-340, 2019 | 27 | 2019 |
| The nucleocapsid protein of human coronavirus NL63 K Zuwała, A Golda, W Kabala, M Burmistrz, M Zdzalik, P Nowak, ... PloS one 10 (2), e0117833, 2015 | 25 | 2015 |
| Triple activity of lamivudine releasing sulfonated polymers against HIV-1 M Danial, AHF Andersen, K Zuwala, S Cosson, CF Riber, AAA Smith, ... Molecular Pharmaceutics 13 (7), 2397-2410, 2016 | 23 | 2016 |
| Characterization of HIV-1 infection and innate sensing in different types of primary human monocyte-derived macrophages EA Diget, K Zuwala, RK Berg, RR Laursen, S Søby, L Østergaard, ... Mediators of inflammation 2013, 2013 | 21 | 2013 |
| Long-acting, potent delivery of combination antiretroviral therapy AHF Andersen, CF Riber, K Zuwala, M Tolstrup, F Dagnæs-Hansen, ... ACS Macro Letters 7 (5), 587-591, 2018 | 19 | 2018 |
| HIV anti-latency treatment mediated by macromolecular prodrugs of histone deacetylase inhibitor, panobinostat K Zuwala, AAA Smith, M Tolstrup, AN Zelikin Chemical Science 7 (3), 2353-2358, 2016 | 18 | 2016 |
| Polymers fight hiv: Potent (pro) drugs identified through parallel automated synthesis K Zuwala, AAA Smith, A Postma, C Guerrero‐Sanchez, P Ruiz‐Sanchis, ... Advanced Healthcare Materials 4 (1), 46-50, 2015 | 18 | 2015 |
| Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects K Zuwala, CF Riber, KB Løvschall, AHF Andersen, L Sørensen, P Gajda, ... Journal of controlled release 275, 53-66, 2018 | 15 | 2018 |
| Macromolecular prodrugs of ribavirin: structure–function correlation as inhibitors of influenza infectivity CF Riber, TM Hinton, P Gajda, K Zuwala, M Tolstrup, C Stewart, ... Molecular Pharmaceutics 14 (1), 234-241, 2017 | 15 | 2017 |
| Polyanionic Macromolecular Prodrugs of Ribavirin: Antiviral Agents with a Broad Spectrum of Activity. TM Hinton, K Zuwala, C Deffrasnes, S Todd, S Shi, GA Marsh, M Dearnley, ... Advanced Healthcare Materials 5 (5), 534-540, 2016 | 13 | 2016 |
| Synthetic polymer with a structure-driven hepatic deposition and curative pharmacological activity in hepatic cells CF Riber, AHF Andersen, LA Rolskov, K Zuwala, P Gajda, KB Løvschall, ... ACS Macro Letters 6 (9), 935-940, 2017 | 4 | 2017 |
| Antiviral conjugates of polyanionic polymer and antiviral drug AN Zelikin, M Tolstrup, K Zuwala, AAA SMITH, RS Pau, M KRYGER US Patent App. 15/580,898, 2019 | | 2019 |
| Macromolecular (Pro) drugs as Potent and Efficacious Antiviral Agents K Zuwala, M Tolstrup, AN Zelikinb Maximize Your Learning, 9, 2016 | | 2016 |
| Antiviral Macromolecular Prodrugs: Mechanism of Action and Structure-function Relationship: PhD Dissertation KW Zuwala Health, University of Aarhus, 2016 | | 2016 |
